Clinical Trial Update: Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of PA9159 inhalation aerosol in adults with bronchial asthma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• PA9159 inhalation aerosol (PA9159)

Snippet

Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. | Conditions: Bronchial Asthma | Phase 2 | Status: RECRUITING